ArticleJournal of assisted reproduction and genetics2025
AMH decline during chemotherapy reflects breast cancer cell DNA damage response (DDR) proficiency: the ONCO AMH1 pilot study.
Christine Decanter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.